Back to search
Substance-Related Disorders
Clinical trial pipeline · Data from ClinicalTrials.gov
See which Substance-Related Disorders trials you may qualify forClinical trial pipeline · Data from ClinicalTrials.gov
See which Substance-Related Disorders trials you may qualify forVending machines are an innovative strategy shown to increase access to naloxone, a medication used to reverse opioid overdose. The aim of this proposal is to s…
Background: Alcohol use disorder (AUD) is a chronic disease that causes more than 140,000 US deaths each year. AUD treatment often includes therapy and medicat…
Background: \- People with alcoholism have differences in their brains compared with healthy people. People who are dependent on alcohol also perform different…
The goal of this clinical trial is to develop a human laboratory model of resilience in people with opioid use disorder (OUD). The investigators aim to learn if…
Background: About 1.5 million adults in the US enter alcohol or substance use treatment programs each year. Unfortunately, more than half of patients do not fi…
Opioid use disorder (OUD) is a treatable medical illness with three medications FDA approved for treatment. However, persons with OUD report significant sleep d…
Background: The purpose of this study is to understand how a type of brain stimulation, transcranial magnetic stimulation (TMS), may help those who use opioids…
Investigators will test a novel protocol for starting BUP (buprenorphine-naloxone) treatment. The BUP microdose induction protocol has participants start very l…